Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Transferases
Reexamination Certificate
2008-07-29
2008-07-29
Davis, Ruth A. (Department: 1657)
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Transferases
C435S006120, C424S009100
Reexamination Certificate
active
10522415
ABSTRACT:
A method of reducing extracellular brain glutamate levels. The method comprises administering to a subject in need thereof a therapeutically effective amount of an agent capable of reducing blood glutamate levels thereby reducing extracellular brain glutamate levels.
REFERENCES:
patent: WO 99/21565 (1999-06-01), None
Rumigny et al, Biochemical Pharmacology, vol. 30, pp. 305-312, 1981.
Geng et al, Journal of Neurochemistry, vol. 68,No. 6, 1997, p. 2500-06.
BL4820 Biochemistry Techiniques□□http://www.bio.mtu.edu/campbell/bl4820/lectures/lec4/gotw41.htm, 1996.
EC2.6.1.1 to EC2.6.1.50□□http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/0601a.html,1976.
Haring et al , Protein Engineering, vol. 15, 2002, p. 603-610.
Matthews et al. “Enzymatic Degradation Protects Neurons From Glutamate Excitotoxicity”, Journal of Neurochemistry, 75(3): 1045-1052, 2000.
Jiang et al. “Glutamate Is A Principal Mediator of HIV-1-Infected Immune Competent Human Macrophage Neurotoxicity”, Society for Neuroscience Abstracts, 26(1-2), Abstract No. 136.17, 30th Annual Meeting of the Society of Neuroscience, New Orleans, USA, 2000.
Di Giorgio et al. “Gabaergic Systems in Brain Regions of Glutamate-Lesioned Rats”, Italien Journal of Biochemistry, 34(1): 19-28, 1985. p. 19, Line 15.
Engelhardt et al. “The Diagnostic Value of Enzyme Determination in Cerebrospinal Fluid”, Medizinische Klinik, München, 71(17): 699-702, 1976. p. 701.
Andrae et al. “Pyruvate and Related α-Ketoacids Protect Mammalian Cells in Culture Against Hydrogen Peroxide-Induced Cytotoxicity”, Toxicology Letters, 28: 93-98, 1985.
Avramis et al. “A Randomized Comparison of NativeEscherichia coliAsparaginase and Polyethelyne Glycol Conjugated Asparaginase for Treatment of Children With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia: A Children's Cancer Group Study”, Blood, 99(6): 1986-1994, 2002.
Cavallini et al. “The Protective Action of Pyruvate on Recovery of Ischemic Rat Heart: Comparison With Other Oxidizable Substrates”, Journal of Molecular Cell Cardiology, 22: 143-154, 1990.
Desagher et al. “Pyruvate Protects Neurons Against Hydrogen Peroxide-Induced Toxicity”, The Journal of Neuroscience, 17(23): 9060-9067, 1997.
Gramsbergen et al. “Pyruvate Protects Against 3-Nitropropionic Acid Neurotoxicity in Corticostriatal Slice Cultures”, Neuropharmacology, 11(21): 2743-2747, 2000.
Hosoya et al. “Blood-Brain Barrier Produces Significant Efflux of L-Aspartic Acid But Not D-Aspartic Acid: In Vivo Evidence Using the Brain Efflux Index Method”, Journal of Neurochemistry, 73: 1206-1211, 1999.
Lee et al. “Protection by Pyruvate Against Transient Forebrain Ischemia in Rats”, The Journal of Neuroscience, 21(RC171): 1-6, 2001.
Liu et al. “P-Glycoprotein Regulated Transport of Glutamate at Blood-Brain Barrier”, Acta Pharmacol Sin, 22(2): 111-116, 2001.
Matsumoto et al. “Role of Pyruvate in Ischemia-Like Conditions on Cultured Neurons”, Neurological Research, 16: 460-464, 1994.
Matthews et al. “Glutamate-Pyruvate Transaminase Protects Against Glutamate Toxicity in Hippocampal Slices”, Brain Research, 978: 59-64, 2003.
Matthews et al. “Enzymatic Degradation Protects Neurons From Glutamate Excitotoxicity”, Journal of Neurochemistry, 75: 1045-1052, 2000.
Maus et al. “Pyruvate and Lactate Protect Striatal Neurons Against N-Methyl-D-Aspartate-Induced Neurotoxicity”, European Journal of Neuroscience, 11: 3215-3224, 1999.
Mongan et al. “Pyruvate Improves Cerebral Metabolism During Hemorrhagic Shock”, AJP—Heart and Circulatory Physiology, 281: 854-864, 2001.
Mongan et al. “Intravenous Pyruvate Prolongs Survival During Hemorrhagic Shock in Swine”, AJP—Heart and Circulatory Physiology, 277(46): H2253-H2263, 1999.
O'Kane et al. “Na+-Independent Glutamate Transporters (EAAT1, EAAT2, and EAAT3) of the Blood-Brain Barrier”, The Journal of Biological Chemistry, 274(45): 31891-31895, 1999.
Ruiz et al. “Protection by Pyruvate and Malate Against Glutamate-Mediated Neurotoxicity”, NeuroReport, 9: 1277-1282, 1998.
Ryu et al. “Neuroprotective Effects of Pyruvate in the Quinolinic Acid Rat Model of Huntington's Disease”, Experimental Neurology, 183: 700-704, 2003.
Steele “Blood-Brain Barrier Transport of the α-Keto Acid Analogs of Amino Acids”, Federation Proceedings, 45(7): 2060-2064, 1986.
Stover et al. “Neurotransmitters in Cerebrospinal Fluid Reflect Pathological Activity”, European Journal of Clinical Investigation, 27: 1038-1043, 1997.
Wolff et al. “The Effectiveness of Benzoate in the Management of Seizures in Nonketotic Hyperglycinemia”, AJDC, 140: 596-602, 1986.
Davis Ruth A.
Gough Tiffany M
Yeda Research And Development Co. Ltd.
LandOfFree
Method and composition for protecting neuronal tissue from... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and composition for protecting neuronal tissue from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for protecting neuronal tissue from... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3907433